INmune Bio

INMB • NASDAQ • Stock Fundamentals

INmune Bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David J. Moss, with a market cap of $33.8M.

Market Cap$33.8M

Employees17.0

CEODavid J. Moss

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about INmune Bio

INmune Bio (INMB) has a market capitalization of $33.8M and trades on NASDAQ.

INmune Bio has approximately 17 employees.